We are live on ! Find out more
CRC

Curi RMB Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 18.93%
This Fund
S&P 500
This Quarter Est. Return
+5.36%
1 Year Est. Return
+18.93%
3 Year Est. Return
+60.65%
5 Year Est. Return
+73.12%
10 Year Est. Return
+312.51%
AUM
$3.87B
AUM Growth
+$377M
Cap. Flow
+$203M
Cap. Flow %
5.25%
Top 10 Hldgs %
14.83%
Holding
811
New
93
Increased
276
Reduced
260
Closed
108

Sector Composition

Rank Sector Weight
1 Financials 20.67%
2 Technology 9.74%
3 Industrials 9.6%
4 Healthcare 9.08%
5 Consumer Discretionary 6.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CWST icon
326
Casella Waste Systems
CWST
$5.76B
$2.72M 0.07%
144,468
-89,252
-38% -$1.52M
TEI
327
Templeton Emerging Markets Income Fund
TEI
$310M
$2.7M 0.07%
+233,217
New +$2.66M
JUNO
328
DELISTED
Juno Therapeutics, Inc.
JUNO
$2.7M 0.07%
+60,090
New +$2.05M
AT
329
DELISTED
Atlantic Power Corporation
AT
$2.67M 0.07%
1,090,000
+79,250
+8% +$190K
EA icon
330
Electronic Arts
EA
$52.7B
$2.66M 0.07%
22,505
+27
+0.1% +$3.13K
NEX
331
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$2.65M 0.07%
158,903
-73,979
-32% -$1.09M
C icon
332
Citigroup
C
$213B
$2.64M 0.07%
36,310
+112
+0.3% +$7.65K
CALD
333
DELISTED
Callidus Software, Inc.
CALD
$2.63M 0.07%
106,598
+15,998
+18% +$389K
BLUE
334
DELISTED
bluebird bio
BLUE
$2.62M 0.07%
+1,474
New +$2.06M
FTEC icon
335
Fidelity MSCI Information Technology Index ETF
FTEC
$18.9B
$2.59M 0.07%
56,028
-605
-1% -$27.2K
SAGE
336
DELISTED
Sage Therapeutics
SAGE
$2.57M 0.07%
41,250
UFPI icon
337
UFP Industries
UFPI
$4.95B
$2.55M 0.07%
78,033
-73,590
-49% -$2.12M
RARE icon
338
Ultragenyx Pharmaceutical
RARE
$2.46B
$2.55M 0.07%
47,895
+8,470
+21% +$502K
FAM
339
DELISTED
First Trust/abrdn Global Opportunity Income Fund
FAM
$2.54M 0.07%
215,849
+168,962
+360% +$1.98M
IBKC
340
DELISTED
IBERIABANK Corp
IBKC
$2.47M 0.06%
30,045
OIS icon
341
Oil States International
OIS
$466M
$2.46M 0.06%
97,218
-45,884
-32% -$1.13M
UNH icon
342
UnitedHealth
UNH
$382B
$2.44M 0.06%
12,432
-28
-0.2% -$5.41K
INXN
343
DELISTED
Interxion Holding N.V.
INXN
$2.37M 0.06%
46,557
+7,020
+18% +$343K
TDY icon
344
Teledyne Technologies
TDY
$29.2B
$2.36M 0.06%
+14,809
New +$2.15M
LPNT
345
DELISTED
LifePoint Health, Inc.
LPNT
$2.35M 0.06%
40,620
+2,690
+7% +$160K
PHLT
346
DELISTED
Performant Healthcare Inc
PHLT
$2.32M 0.06%
1,276,583
+96,069
+8% +$182K
PEP icon
347
PepsiCo
PEP
$196B
$2.31M 0.06%
20,684
-285
-1% -$32.9K
GHY
348
PGIM Global High Yield Fund
GHY
$476M
$2.29M 0.06%
+153,269
New +$2.29M
AMG icon
349
Affiliated Managers Group
AMG
$9.51B
$2.27M 0.06%
11,938
+263
+2% +$46.8K
GNBC
350
DELISTED
Green Bancorp, Inc
GNBC
$2.26M 0.06%
95,690
-123,310
-56% -$2.63M

Similar funds

Curi RMB Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Curi RMB Capital held 811 positions worth $3.87B, up 11% from $3.49B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Curi RMB Capital deployed $203M of net new capital in Q3 2017, opening 93 new positions and adding to 276 existing holdings. Its largest new stake was Live Oak Bancshares: 826,709 shares worth $19.4M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Pacific Premier Bancorp, an estimated $10.9M trimmed.

  • Curi RMB Capital's largest Q3 2017 buy was Live Oak Bancshares: 826,709 shares worth $19.4M.
  • Curi RMB Capital added most to FB Financial Corp in Q3 2017, an estimated $16.1M increase.
  • Curi RMB Capital's biggest Q3 2017 reduction was Pacific Premier Bancorp, cutting an estimated $10.9M.
  • Curi RMB Capital fully exited Discovery, Inc. Series C Common Stock in Q3 2017, selling an estimated $18.5M.
  • Curi RMB Capital's ten largest holdings make up 15% of its $3.87B portfolio in Q3 2017.
  • Curi RMB Capital opened 93 new positions and closed 108 in Q3 2017.
  • Curi RMB Capital's portfolio value rose 11% quarter-over-quarter to $3.87B.

Based on Curi RMB Capital's 13F filing for Q3 2017, filed 14 Nov 2017.